ClinicalTrials.Veeva

Menu

Prospective Cohort Study of Patients Intolerant to High Pressure Under Continuous Positive Airway Pressure Treated With Bilevel Positive Airway Pressure as Second-line Therapy. (PoP IN VAuto)

ResMed logo

ResMed

Status

Terminated

Conditions

Obstructive Sleep Apnea

Study type

Observational

Funder types

Industry

Identifiers

NCT02930460
PoP IN VAuto

Details and patient eligibility

About

Prospective observational study of obstructive Sleep Apnea patients treated with Bilevel Positive Airway Pressure: AirCurve 10 VAutoTM

Full description

To characterize, in routine practice, non compliant patient to continuous positive airway pressure who can get a benefit of a bilevel positive airway pressure therapy as a second line treatment (Aircurve 10 VAutoTM ) To evaluate the clinical management of obstructive sleep apnea patients treated by Aircurve 10 VAutoTM , especially impact on compliance and residual apnea hypopnea Index.

To evaluate Aircurve 10 VAutoTM benefit on quality of Life and quality of sleep

Enrollment

30 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patient
  • Obstructive Sleep Apnea Patient previously treated by Continuous positive airway pressure non-compliant to therapy
  • Patient naive of bilevel Positive Airway Pressure therapy

Exclusion criteria

  • Bilevel positive airway pressure Contraindication
  • Severe respiratory disease diagnostic

Trial contacts and locations

8

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems